Genedx Holdings Corp (WGS) Stock Price, Quote & News

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 888 729 1206

Fax: 201 421 2010

Website: www.genedx.com

Address:

North Tower, 6th Floor 333 Ludlow Street, Stamford, United States

PhishTourFunds Feb. 15 at 12:49 AM

$WGS Sitting at $95 (hey thats one of my shitty lines!) and looking like a buy

0 · Reply

Bio_Be_Dirty Feb. 13 at 6:55 PM

$WGS pump over

0 · Reply

DailyAnalysis Feb. 9 at 4:59 PM

$WGS 1W momentum is fading with 1D RSI 29 hitting deep oversold. 4H STOCH is stabilizing while 30M CCI flags an immediate technical bounce potential. @DailyAnalysis

0 · Reply

DailyAnalysis Feb. 9 at 4:56 PM

$WGS 1W momentum is fading with 1D RSI 29 hitting deep oversold. 4H STOCH is stabilizing while 30M CCI flags an immediate technical bounce potential. @DailyAnalysis

0 · Reply

notreload_ai Feb. 9 at 11:34 AM

Wells Fargo upgrades $WGS to Overweight, saying the recent stock decline looks excessive and growth opportunities could drive momentum into 2026. https://notreload.xyz/wells-fargo-upgrades-genedx-analysts-see-strong-upside-after-stock-drop/

0 · Reply

Mike18181 Feb. 7 at 12:49 AM

$WGS PingpongDx. A genomics yoyo stock that is all over the table. As investors get paddled !!!

0 · Reply

Mike18181 Feb. 7 at 12:44 AM

$WGS stock sold off as Insiders did this. Timing before a ER.. Low float gets this killed. Bad and who knows causing it to get drilled somemore. Reckless by SpleenDx

0 · Reply

spongebob_squaretrades Feb. 6 at 8:55 PM

$WGS Filled the gap from end of July 2025. 50% retracement from the all-time high. On support.

0 · Reply

Eddyg987 Feb. 6 at 6:13 PM

$WGS why would the COO sell right before earnings?? big clue guys

3 · Reply

youownitall Feb. 5 at 4:10 PM

$WGS needs way more margin of safety before the ER or it will tank. NFA

0 · Reply

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Feb 5, 2026, 1:50 AM EST - 11 days ago

Polen 5Perspectives Small Growth Portfolio Performance & Attribution

Feb 3, 2026, 8:00 AM EST - 13 days ago

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Jan 15, 2026, 11:24 AM EST - 4 weeks ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Jan 14, 2026, 8:15 PM EST - 4 weeks ago

GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 10:21 AM EST - 4 weeks ago

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

Jan 12, 2026, 3:03 PM EST - 4 weeks ago

Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 7:30 AM EST - 5 weeks ago

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Jan 8, 2026, 8:30 AM EST - 5 weeks ago

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

Jan 7, 2026, 8:30 AM EST - 5 weeks ago

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Jan 6, 2026, 8:30 AM EST - 5 weeks ago

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Jan 5, 2026, 8:30 AM EST - 6 weeks ago

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Dec 30, 2025, 8:00 AM EST - 6 weeks ago

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 15, 2025, 8:30 AM EST - 2 months ago

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Dec 11, 2025, 10:37 AM EST - 2 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA PODD UNH

Nov 30, 2025, 3:20 PM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Nov 18, 2025, 12:59 PM EST - 3 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP

Nov 6, 2025, 8:00 AM EST - 3 months ago

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Nov 4, 2025, 8:00 AM EST - 3 months ago

GeneDx to Participate in Upcoming Investor Conferences

Oct 28, 2025, 3:41 PM EDT - 3 months ago

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 6:30 AM EDT - 3 months ago

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Oct 27, 2025, 8:00 AM EDT - 4 months ago

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

Oct 27, 2025, 8:00 AM EDT - 4 months ago

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Oct 22, 2025, 8:00 AM EDT - 4 months ago

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Oct 20, 2025, 8:00 AM EDT - 4 months ago

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Oct 15, 2025, 3:30 PM EDT - 4 months ago

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

Oct 15, 2025, 11:45 AM EDT - 4 months ago

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Oct 15, 2025, 9:15 AM EDT - 4 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

ILMN

Oct 15, 2025, 2:55 AM EDT - 4 months ago

GeneDx's Blueprint For The Next Healthcare Revolution

Oct 14, 2025, 3:17 PM EDT - 4 months ago

How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 8:00 AM EDT - 4 months ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 13, 2025, 8:00 AM EDT - 4 months ago

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

Oct 9, 2025, 8:00 AM EDT - 4 months ago

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

Oct 8, 2025, 8:00 AM EDT - 4 months ago

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

Oct 7, 2025, 8:00 AM EDT - 4 months ago

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

Oct 1, 2025, 4:01 PM EDT - 4 months ago

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Sep 30, 2025, 8:00 AM EDT - 4 months ago

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Sep 25, 2025, 8:00 AM EDT - 5 months ago

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

Sep 18, 2025, 8:00 AM EDT - 5 months ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

Sep 8, 2025, 10:45 AM EDT - 5 months ago

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 7:00 AM EDT - 5 months ago

Seer Appoints Isaac Ro to its Board of Directors

SEER

Aug 6, 2025, 9:30 AM EDT - 6 months ago

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

Jul 31, 2025, 10:22 AM EDT - 7 months ago

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

Jul 31, 2025, 3:30 AM EDT - 7 months ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

Jul 30, 2025, 5:07 PM EDT - 7 months ago

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

Jul 30, 2025, 8:38 AM EDT - 7 months ago

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

Jul 29, 2025, 5:06 PM EDT - 7 months ago

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

PhishTourFunds Feb. 15 at 12:49 AM

$WGS Sitting at $95 (hey thats one of my shitty lines!) and looking like a buy

0 · Reply

Bio_Be_Dirty Feb. 13 at 6:55 PM

$WGS pump over

0 · Reply

DailyAnalysis Feb. 9 at 4:59 PM

$WGS 1W momentum is fading with 1D RSI 29 hitting deep oversold. 4H STOCH is stabilizing while 30M CCI flags an immediate technical bounce potential. @DailyAnalysis

0 · Reply

DailyAnalysis Feb. 9 at 4:56 PM

$WGS 1W momentum is fading with 1D RSI 29 hitting deep oversold. 4H STOCH is stabilizing while 30M CCI flags an immediate technical bounce potential. @DailyAnalysis

0 · Reply

notreload_ai Feb. 9 at 11:34 AM

0 · Reply

Mike18181 Feb. 7 at 12:49 AM

$WGS PingpongDx. A genomics yoyo stock that is all over the table. As investors get paddled !!!

0 · Reply

Mike18181 Feb. 7 at 12:44 AM

$WGS stock sold off as Insiders did this. Timing before a ER.. Low float gets this killed. Bad and who knows causing it to get drilled somemore. Reckless by SpleenDx

0 · Reply

spongebob_squaretrades Feb. 6 at 8:55 PM

$WGS Filled the gap from end of July 2025. 50% retracement from the all-time high. On support.

0 · Reply

Eddyg987 Feb. 6 at 6:13 PM

$WGS why would the COO sell right before earnings?? big clue guys

3 · Reply

youownitall Feb. 5 at 4:10 PM

$WGS needs way more margin of safety before the ER or it will tank. NFA

0 · Reply

Macarran Feb. 5 at 2:08 PM

$WGS https://www.quiverquant.com/news/Insider+Sale%3A+Chief+Operating+Officer+of+%24WGS+Sells+1%2C662+Shares

0 · Reply

v92 Feb. 5 at 1:10 PM

$WGS

0 · Reply

tymtested Feb. 5 at 1:06 PM

$WGS the forecasted financials do not support the rich stats.

0 · Reply

NasdaqPulse Feb. 5 at 10:26 AM

Why Cathie Wood is all-in on $WGS & $CRWV ARK Feb 4 rebalance = structural shift 1️⃣ Data Play — $WGS Largest clinical genomic library = AI “training set” for cures. 65% YoY growth. Legacy diagnostics out. 2️⃣ Compute Play — $CRWV “Anti-AWS” built for GPUs. ARK buying dips. AI boom needs specialized clouds. 3️⃣ Rotation Selling $TER & $TTD to fund AI-native bets. If it’s not AI-native, it’s a source of funds.

0 · Reply

Eddyg987 Feb. 4 at 7:11 PM

$WGS Cathy really know how to pick them, I don't know much about this stock, but tend to get killed when I follow Cathy.

1 · Reply

CatRocks Feb. 4 at 5:54 PM

$WGS Went through the 85.19 gap-fill. Now there's a support of 80.22. I hope it holds. Added to position.

0 · Reply

Bio_Be_Dirty Feb. 4 at 5:41 PM

$WGS getting crushed

0 · Reply

tymtested Feb. 4 at 5:37 PM

$WGS another victim of AI... hhhmmmm....

0 · Reply

CatRocks Feb. 4 at 3:41 PM

$WGS Almost there!

0 · Reply

WundagoreWaves Feb. 4 at 9:39 AM

$WGS grocery retail, online competition

0 · Reply

11thestate Feb. 3 at 12:45 PM

Don't forget that there is also an important settlement to watch for $WGS. We have every detail, including how investors can get paid: https://11th.com/cases/cmls-investor-settlement

0 · Reply

EquityClock Feb. 2 at 5:26 PM

We have the list of all securities that have gained in EVERY February over their trading history: https://equityclock.com/2026/01/31/stock-market-outlook-for-february-2-2026/ $DKNG $QNTM $WGS

0 · Reply

Market Cap	2.61B
Revenue (ttm)	305.45M
Net Income (ttm)	-52.29M
EPS (ttm)	N/A
PE Ratio	46.03
Forward PE	156.33
Profit Margin	-17.12%
Debt to Equity Ratio	0.18

Volume	627,800
Avg Vol	608,304
Day's Range	N/A - N/A
Shares Out	28.91M
Stochastic %K	42%
Beta	2.00
Analysts	Strong Sell
Price Target	$170.00